Sancy A. Leachman

11.0k total citations
185 papers, 5.3k citations indexed

About

Sancy A. Leachman is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Sancy A. Leachman has authored 185 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Oncology, 65 papers in Molecular Biology and 44 papers in Dermatology. Recurrent topics in Sancy A. Leachman's work include Cutaneous Melanoma Detection and Management (73 papers), Skin Protection and Aging (32 papers) and Melanoma and MAPK Pathways (27 papers). Sancy A. Leachman is often cited by papers focused on Cutaneous Melanoma Detection and Management (73 papers), Skin Protection and Aging (32 papers) and Melanoma and MAPK Pathways (27 papers). Sancy A. Leachman collaborates with scholars based in United States, United Kingdom and Italy. Sancy A. Leachman's co-authors include Pamela B. Cassidy, Douglas Grossman, Kenneth M. Boucher, Zalfa Abdel‐Malek, Scott R. Florell, Ana Luisa Kadekaro, Lisa G. Aspinwall, Roger L. Kaspar, Frances J.D. Smith and Leonard M. Milstone and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sancy A. Leachman

179 papers receiving 5.2k citations

Peers

Sancy A. Leachman
Julia Newton‐Bishop United Kingdom
David M. Owens United Kingdom
Lloyd E. King United States
Qun Lin China
Constantin E. Orfanos Germany
Michael P. Philpott United Kingdom
Ken Watanabe Japan
Eli Sprecher Israel
John J. DiGiovanna United States
Richard W. Sagebiel United States
Julia Newton‐Bishop United Kingdom
Sancy A. Leachman
Citations per year, relative to Sancy A. Leachman Sancy A. Leachman (= 1×) peers Julia Newton‐Bishop

Countries citing papers authored by Sancy A. Leachman

Since Specialization
Citations

This map shows the geographic impact of Sancy A. Leachman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sancy A. Leachman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sancy A. Leachman more than expected).

Fields of papers citing papers by Sancy A. Leachman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sancy A. Leachman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sancy A. Leachman. The network helps show where Sancy A. Leachman may publish in the future.

Co-authorship network of co-authors of Sancy A. Leachman

This figure shows the co-authorship network connecting the top 25 collaborators of Sancy A. Leachman. A scholar is included among the top collaborators of Sancy A. Leachman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sancy A. Leachman. Sancy A. Leachman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, Elizabeth, Reid F. Thompson, Catherine M. Shachaf, & Sancy A. Leachman. (2025). Molecular Imaging in Early Skin Cancer Detection: Advances, Limitations, and Future Directions. Technology in Cancer Research & Treatment. 24. 2244151961–2244151961.
2.
Łudzik, Joanna, et al.. (2024). Revolutionizing Skin Cancer Triage: The Role of Patient-Initiated Teledermoscopy in Remote Diagnosis. Cancers. 16(14). 2565–2565. 1 indexed citations
3.
Butterfield, Richard, et al.. (2024). Social media as a recruitment tactic in melanoma education and protective behaviors in Latino patients. SHILAP Revista de lepidopterología. 3(3). 844–849.
4.
Roop, Dennis R., Thomas Krieg, Sabine Werner, et al.. (2024). Montagna Symposium on the Biology of Skin 70th Anniversary: Visualizing the Future!. Journal of Investigative Dermatology. 144(10). 2120–2124. 1 indexed citations
5.
Wu, Yelena P., Tammy K. Stump, Jennifer L. Hay, et al.. (2023). The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors. Contemporary Clinical Trials. 131. 107276–107276. 1 indexed citations
6.
Butterfield, Richard, et al.. (2023). Increase in melanoma knowledge in Latino patients after a targeted digital educational program. JAAD International. 14. 61–63. 2 indexed citations
7.
Steele, Maria M., Ian Dryg, Dhaarini Murugan, et al.. (2023). T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nature Immunology. 24(4). 664–675. 71 indexed citations
8.
Latour, Emile, et al.. (2023). 40901 The benefit of early-stage diagnosis: A registry-based survey evaluating quality of life in patients with melanoma. Journal of the American Academy of Dermatology. 89(3). AB231–AB231. 2 indexed citations
9.
Ito, Shosuke, Kazumasa Wakamatsu, Gary F. Merrill, et al.. (2022). Thioredoxin Reductase 1 Modulates Pigmentation and Photobiology of Murine Melanocytes in vivo. Journal of Investigative Dermatology. 142(7). 1903–1911.e5. 10 indexed citations
10.
Semir, David de, Vladimir Bezrookove, Mehdi Nosrati, et al.. (2021). Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility. Cancer Research. 81(11). 2956–2969. 12 indexed citations
11.
Ngamcherdtrakul, Worapol, Moataz Reda, Molly A. Nelson, et al.. (2021). In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response. Advanced Materials. 33(31). e2100628–e2100628. 61 indexed citations
12.
Chang, Michael S., Sancy A. Leachman, Elizabeth Berry, et al.. (2021). Changes in melanoma care practices during the COVID-19 pandemic: a multi-institutional cross-sectional survey. Dermatology Online Journal. 27(4). 7 indexed citations
13.
Taber, Jennifer M., Lisa G. Aspinwall, Tammy K. Stump, et al.. (2020). Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma. Annals of Behavioral Medicine. 55(1). 24–40. 3 indexed citations
14.
André, Josette, et al.. (2019). Immunohistochemical characterization of benign activation of junctional melanocytes and melanoma in situ of the nail unit. Journal of Cutaneous Pathology. 46(7). 479–483. 8 indexed citations
15.
Leachman, Sancy A., Thomas J. Hornyak, Gregory S. Barsh, et al.. (2019). Melanoma to Vitiligo: The Melanocyte in Biology & Medicine–Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting. Journal of Investigative Dermatology. 140(2). 269–274. 4 indexed citations
16.
Wu, Yelena P., Kenneth M. Boucher, Nan Hu, et al.. (2019). A pilot study of a telehealth family‐focused melanoma preventive intervention for children with a family history of melanoma. Psycho-Oncology. 29(1). 148–155. 4 indexed citations
17.
18.
Cassidy, Pamela B., Tong Liu, Scott R. Florell, et al.. (2016). A Phase II Randomized Placebo-Controlled Trial of Oral N -acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress In Vivo. Cancer Prevention Research. 10(1). 36–44. 20 indexed citations
19.
Clarke, Loren E., M. Bryan Warf, Darl D. Flake, et al.. (2015). Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. Journal of Cutaneous Pathology. 42(4). 244–252. 108 indexed citations
20.
Linden, Kenneth G., Sancy A. Leachman, Jonathan S. Zager, et al.. (2014). A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology. Cancer Prevention Research. 7(5). 496–504. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Newton‐Bishop Breakdown of academic impact, for papers by David M. Owens Breakdown of academic impact, for papers by Lloyd E. King Breakdown of academic impact, for papers by Qun Lin Breakdown of academic impact, for papers by Constantin E. Orfanos Breakdown of academic impact, for papers by Michael P. Philpott Breakdown of academic impact, for papers by Ken Watanabe Breakdown of academic impact, for papers by Eli Sprecher Breakdown of academic impact, for papers by John J. DiGiovanna Breakdown of academic impact, for papers by Richard W. Sagebiel
Rankless by CCL
2026